Background Although non-alcoholic fatty liver disease (NAFLD) is commonly associated
with obesity, it is increasingly being identified in non-obese individuals. We aimed to …

NAFLD has become a major public health problem for more than 2 decades with a growing
prevalence in parallel with the epidemic of obesity and type 2 diabetes (T2D). The disease …

Following the epidemics of obesity, nonalcoholic fatty liver disease (NAFLD) has become
the leading cause of liver disease in western countries. NAFLD is the hepatic manifestation …

Vitamin D is an important secosteroid hormone with known effect on calcium homeostasis,
but recently there is increasing recognition that vitamin D also is involved in cell proliferation …

The prevalence and impact of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic
steatohepatitis (NASH) have continued to increase in recent years. Previous reports have …

Non-alcoholic fatty liver disease (NAFLD) is histologically classified as either non-alcoholic
fatty liver or non-alcoholic steatohepatitis (NASH). NASH is the progressive subtype of …

Nonalcoholic fatty liver disease (NAFLD), historically considered to be the hepatic
component of the metabolic syndrome, is a spectrum of fat-associated liver conditions, in the …

The flexibility between the wide array of hepatic functions relies on calcium (Ca 2+)
signalling. Indeed, Ca 2+ is implicated in the control of many intracellular functions as well …

We aimed to explore the potential link of serum vitamin D level with nonalcoholic fatty liver
disease (NAFLD). PubMed, Embase and the Cochrane Library database were searched …

Background and aims It has been reported that 1, 25 (OH) 2 D 3 (1, 25-VD 3) ameliorates
the progression of nonalcoholic steatohepatitis (NASH). However, it is unclear whether 1, 25 …